https://de.marketscreener.com/kurs/aktie/PHIO-PHARMACEUTICALS-CORP-47281669/news/Phio-Pharmaceuticals-Corp-gibt-die-Verabreichung-des-ersten-Patienten-in-der-gemeinsamen-klinischen-44660969/?utm_source=telegram&utm_medium=social&utm_campaign=share